Lei Company has launched the TuneLab platform, opening AI drug discovery models to biotechnology companies.

On September 9th, Eli Lilly announced that it will launch an artificial intelligence and machine learning platform called TuneLab, which will be open to biotechnology companies to train AI drug discovery models based on their years of research data. Lilly stated that the AI model being launched includes proprietary data obtained through an investment of over $1 billion.